Vincristine (generic), Oncovin, Vincasar Newswire

Vincristine (generic), Oncovin, Vincasar Newswire

Comprehensive Real-Time News Feed for Vincristine (generic), Oncovin, Vincasar.

Results 1 - 20 of 86 in Vincristine (generic), Oncovin, Vincasar

  1. The treatment of primary mediastinal large B-cell lymphoma: a two...Read the original story w/Photo

    Sunday Apr 16 | BioMed Central

    The purpose of this study is to investigate the most suitable first-line approach and the best combination treatment for primary mediastinal large B-cell lymphoma as they have been matter of debate for at least two decades. Our single centre experience in the treatment of 98 de novo PMLBCL patients over the last 20 years is reviewed.

    Comment?

  2. High Incidence of HIV/AIDS, Organ Transplants Driving Growth of Kaposi Sarcoma MarketRead the original story w/Photo

    Friday Apr 14 | SBWire

    Kaposi sarcoma refers to a type of cancer that develops from the cells lining blood vessels or lymph nodes. The cancer usually appears as tumors on mucosal surfaces or on the skin, but can also develop in body parts such as the digestive tract, or the lungs.

    Comment?

  3. Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Estimated to Flourish by 2022Read the original story w/Photo

    Thursday Apr 13 | SBWire

    Glioblastoma multiforme is the most common and aggressive malignant brain tumor in humans that involves glial cells. GBM is present in two variants namely, giant cell glioblastoma and gliosarcoma.

    Comment?

  4. Anticholangiocarcinoma activity and toxicity of the Kaempferia...Read the original story w/Photo

    Tuesday Apr 11 | BioMed Central

    Cholangiocarcinoma is an important public health problem in several tropical and subtropical parts of the world particularly Thailand. Chemotherapy of CCA is largely ineffective and discovery and development of effective alternative drugs is urgently needed.

    Comment?

  5. Antiparasitic drug, the next weapon against brain cancer?Read the original story w/Photo

    Wednesday Apr 12 | The Daily Millbury

    Keep your brain healthy! Soon, a common pinworm medication could replace the current treatment used for certain brain cancers. These findings from the Feinstein Institute for Medical Research's Karches Center for Oncology Research could help to extend the lives of patients suffering from one of the most common types of brain tumours, low-grade glioma.

    Comment?

  6. Feinstein Institute research may lead to new treatment option for low-grade gliomasRead the original story w/Photo

    Tuesday Apr 11 | Medical News

    Marc Symons, PhD, professor in The Feinstein Institute for Medical Research's Karches Center for Oncology Research, is examining if a common medication administered to treat pinworms, could replace the current treatment used for certain brain cancers. These findings, which are published today in the Feinstein Institute Press's peer-reviewed, open-access journal Molecular Medicine , could help to extend the lives of patients suffering from one of the most common types of brain tumors -- low-grade glioma.

    Comment?

  7. Antiparasitic drug may be new treatment for brain tumorsRead the original story w/Photo

    Tuesday Apr 11 | UPI

    A new study shows that a common antiparasitic medication could be effective at treating certain brain cancers including low-grade glioma. Low-grade glioma is a tumor that originates from cells that protect and support the brain's nervous system.

    Comment?

  8. Team examines use of antiparasitic drug as new treatment for brain tumorsRead the original story w/Photo

    Tuesday Apr 11 | PhysOrg Weblog

    Marc Symons, PhD, professor at the Feinstein Institute for Medical Research is examining if a common medication administered to treat pinworms, could replace the current treatment used for certain brain cancers. Credit: Northwell Health Marc Symons, PhD, professor in The Feinstein Institute for Medical Research's Karches Center for Oncology Research, is examining if a common medication administered to treat pinworms, could replace the current treatment used for certain brain cancers.

    Comment?

  9. Feinstein Institute examines use of antiparasitic drug as new treatment for brain tumorsRead the original story w/Photo

    Monday Apr 10 | EurekAlert!

    Marc Symons, PhD, professor in The Feinstein Institute for Medical Research's Karches Center for Oncology Research, is examining if a common medication administered to treat pinworms, could replace the current treatment used for certain brain cancers. These findings, which are published today in the Feinstein Institute Press's peer-reviewed, open-access journal Molecular Medicine , could help to extend the lives of patients suffering from one of the most common types of brain tumors -- low-grade glioma.

    Comment?

  10. Optimal treatment and prognostic factors for esthesioneuroblastoma:...Read the original story w/Photo

    Monday Apr 10 | BioMed Central

    We retrospectively assessed the clinicopathological features, prognostic factors and treatment methods for 187 patients with esthesioneuroblastoma treated in China between 1981 and 2015. Overall survival and disease-free survival were evaluated using the Kaplan-Meier method and log-rank tests.

    Comment?

  11. Liposarcoma Treatment Market to Record an Exponential CAGR by 2022Read the original story w/Photo

    Friday Apr 7 | SBWire

    Liposarcoma is a cancer of fat cells lying deep within the soft tissues, typically in retroperitoneum or thighs. According to WHO, liposarcoma is the most common type of sarcomas and accounts for approximately 17-20% of all cases of sarcoma.

    Comment?

  12. Catharanthine Market Value Chain and Forecast 2016-2026Read the original story w/Photo

    Sunday Apr 2 | PR-inside.com

    Future Market Insights has announced the addition of the "Catharanthine Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering. Medicinal plants today form a major portion of rich biodiversity globally and are still not explored to its potential.

    Comment?

  13. Global Multiple Myeloma Therapeutics Market Size and Forecast Report 2021Read the original story

    Thursday Mar 30 | Emailwire.com

    Multiple Myeloma Therapeutics Market by Treatment Type, Drug Type and Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts According to the report Multiple Myeloma Therapeutics Market , published by Market Data Forecast, the global market is projected to reach USD 9.1 Billion by 2021, at a CAGR of 4.8% from 2016 to 2021. For full report refer to Multiple myeloma remains comparatively rare, it is a deceptive disease and patients typically deplete treatment alternatives.

    Comment?

  14. Surprising culprit in nerve cell damage identifiedRead the original story w/Photo

    Mar 22, 2017 | EurekAlert!

    IMAGE: In many neurodegenerative conditions -- Parkinson's disease, amyotrophic lateral sclerosis and peripheral neuropathy among them -- an early defect is the loss of axons. When axons are lost, nerve... view more In many neurodegenerative conditions -- Parkinson's disease, amyotrophic lateral sclerosis and peripheral neuropathy among them -- an early defect is the loss of axons, the wiring of the nervous system.

    Comment?

  15. New research reveals surprising culprit involved in self-destruction of axonsRead the original story w/Photo

    Mar 24, 2017 | Medical News

    In many neurodegenerative conditions - Parkinson's disease, amyotrophic lateral sclerosis and peripheral neuropathy among them - an early defect is the loss of axons, the wiring of the nervous system. When axons are lost, nerve cells can't communicate as they should, and nervous system function is impaired.

    Comment?

  16. Surprising Culprit in Nerve Cell Damage IdentifiedRead the original story

    Mar 23, 2017 | Newswise

    In many neurodegenerative conditions - Parkinson's disease, amyotrophic lateral sclerosis and peripheral neuropathy among them - an early defect is the loss of axons, the wiring of the nervous system. When axons are lost, nerve cells can't communicate as they should, and nervous system function is impaired.

    Comment?

  17. Findings suggest ways to block nerve cell damage in neurodegenerative diseasesRead the original story w/Photo

    Mar 23, 2017 | PhysOrg Weblog

    Nerve axons serve as the electrical wiring of the nervous system. Scientists have implicated a specific molecule in triggering a self-destruct program in axons that leads to their degeneration .

    Comment?

  18. Multiparametric cardiac magnetic resonance imaging (CMR) for the...Read the original story

    Mar 10, 2017 | BioMed Central

    Endocarditis parietalis fibroplastica LA fflein is a rare form of primary restrictive cardiomyopathy with poor prognosis. It is generally caused by hypereosinophilic syndrome with eosinophilic penetration of the heart.

    Comment?

  19. Improving disclosure of medical error through educational program as...Read the original story w/Photo

    Mar 3, 2017 | BioMed Central

    Although physicians believe that medical errors should be disclosed to patients and their families, they often hesitate to do so. In this study, we assessed the effectiveness of an education program for medical error disclosure.

    Comment?

  20. Catharanthine Market 2016-2026 Shares, Trend and Growth ReportRead the original story w/Photo

    Feb 26, 2017 | PR-inside.com

    Future Market Insights has announced the addition of the "Catharanthine Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering. Medicinal plants today form a major portion of rich biodiversity globally and are still not explored to its potential.

    Comment?